X4 Pharmaceuticals, Inc. Gains 17.33%

X4 Pharmaceuticals, Inc. (XFOR:NASDAQ) jumped higher at $2.37, a gain of 17.3%. On Wed, Dec 15, 2021, XFOR:NASDAQ hit a New 2-Week Intraday Low of $1.8. The stock got featured on our News Catalysts scanner on Mon, Dec 13, 2021 at 08:43 AM in the 'BIOTECH' category. From Wed, Dec 01, 2021, the stock recorded 40.00% Up Days and 27.27% Green Days

About X4 Pharmaceuticals, Inc. (XFOR:NASDAQ)

Arsanis Inc discovers and develops monoclonal antibodies for the targeted immunotherapy of serious infections. The company's monoclonal antibodies selectively focus on specific pathogens and pathogenic processes which address critical infections while minimizing the collateral damage from antimicrobial overuse, resistance, and microbiome disruption. Few of its products candidates are ASN100, for prevention of pneumonia in high risk, mechanically ventilated patients; ASN500, for prevention of respiratory Syncytial virus; ASN300 and ASN200, for prevention and treatment of bacterial infections.